0
Is olaparib the only PARP inhibitor that has been approved?
- 1 people answered
0 Vote
1 Contributor
1589 Views 
0 Saved
0 Vote 1 Contributor1589 Views 0 SavedYou might also be interested in
Good news! The short answer is a resounding no. Cow milk’s relationship with breast cancer has been studied extensively over the past 25 years, and while the details of the studies don’t always agree, most of the studies agree on the basics: that dairy is not associated with an increased risk for br....
Only decades ago doctors and health professionals used to warn about the negative effects of having too much coffee because of the risk that caffeine was believed to have on your body. However, the last decade has shed so much light on the health benefits of coffee and its relationship with can....
HER2 is a gene that creates HER2 proteins or receptors. These receptors help control growth and repair of breast cells. An overexpression of HER2 protein causes out-of-control reproduction of breast cells. HER2-positive breast cancers are known to be more aggressive than HER2-negative breast canc....
Rahul Sharma
Yes, PARP inhibitors are relatively newer class of drugs and scientists have just begun to explore their functionality and usage in Cancer treatment. LYNPARZA is the first and only PARP inhibitor approved in 2 distinct settings: For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in complete or partial response to platinum-based chemotherapy. For the treatment of adult patients with suspected deleterious germline BRCA-mutated advanced ovarian cancer which has been treated with 3 or more prior lines of chemotherapy. Patients should be selected for therapy based on an FDA-approved companion diagnostic for LYNPARZA. Poly (ADP-ribose) Polymerase, or PARP, enzymes mediate DNA repair by transferring ADP-ribose units to preexisting ADP-ribose chains on proteins and to proteins. This ADP–ribosylation process recruits DNA repair enzymes, thereby maintaining genomic integrity. Inhibiting this process can lead to the accumulation of DNA damage and, ultimately, cell death.